# A First in Human Study, Evaluating the Safety and Efficacy of ADAM™ 1.0

> **NCT05134428** · NA · COMPLETED · sponsor: **Contraline, Inc** · enrollment: 25 (actual)

## Conditions studied

- Male Contraception
- Healthy Male Adults

## Interventions

- **DEVICE:** ADAM System

## Key facts

- **NCT ID:** NCT05134428
- **Lead sponsor:** Contraline, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-20
- **Primary completion:** 2024-03-20
- **Final completion:** 2026-03-08
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05134428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05134428, "A First in Human Study, Evaluating the Safety and Efficacy of ADAM™ 1.0". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05134428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*